Health
Start-up receives NIH grant to accelerate development of contrast agent to detect liver fibrosis – News-Medical.Net
Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Instit…

Reviewed by Emily Henderson, B.Sc.Oct 15 2020
Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Institute of Health grant to accelerate development of a magnetic resonance imaging contrast agent to detect liver fibrosis, formation of scar tissue in the liver caused by alcoholic and non-alcoholic fatty liver disease.
We have been working on this breakthrough in the lab for several years. This…
-
Noosa News7 hours ago
How Lily Steele-Park took her rapist to court and won
-
General21 hours ago
‘Potential’ hacker contacts Qantas over data breach
-
Business11 hours ago
Ford CEO makes stunning prediction about artificial intelligence
-
General22 hours ago
Qantas ‘contacted by potential cybercriminal’ after attack on data of up to 6 million customers